IM
Immunovia AB
IMMVF · OTC
$0.01 +0.00% (+$0.00)
Market Cap 30.0M kr
P/E Ratio -
Div. Yield -
ROE 278.79%
Piotroski F-Score Weak
1/9Valuation
50 /100
Fair P/S 24.88x
P/B 1.27x
P/E N/A
Growth
0 /100
Declining Rev. growth 15.81%
Book val. growth 35.78%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 1,308.72%
FCF margin 6,839.85%
Net margin 7,287.72%
Quality
0 /100
Poor ROIC 271.27%
Asset turnover 0.03x
ROE 278.79%
Debt
64 /100
Moderate Debt/Equity 0.14x
Int. coverage -9.66x
Current ratio 1.57x
Stability
11 /100
Unstable Beta 2.65x
Profitable years 0
Rev. volatility 41.78%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about IMMVF
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Jeff Borcherding
Employees
13
Headquarters
Lund
Upcoming events
05 NOV
Earnings
Upcoming earnings report